Dysregulation of cell adhesion-associated molecules has been identified in the development of PTC: CD44 has been implicated in promoting tumor metastasis and lymphatic invasion (30), while galectin-3 exhibits lower expression correlating with increased cancer metastasis potential but higher expression aiding PTC diagnosis (31). Here, CD44 is linked to cancer.